New GARD® data on Fragrances, Complex Mixtures, and Biopesticides
Join us for the first webinar in a series focusing on in vitro skin sensitization potency assessment. In this opening session, we will address common challenges in potency testing and highlight new GARD® data generated through scientific collaborations with Coty, dōTERRA, and Bayer, recently presented at the 2026 SOT Annual Meeting.
You will gain insight into typical use scenarios for GARD® skin Dose-Response, and learn how this single-assay method, based on genomics and machine-learning technology, supports critical decision-making during product development, including how to:
- Define safe dose levels for materials with expected sensitizing potential.
- Derive reference NESIL values to support confirmatory human patch testing.
- Establish a Point-of-Departure (PoD) for quantitative risk assessment.
With broad applicability to complex mixtures and novel raw materials with challenging properties, GARD® provides a powerful non-animal solution for assessing skin sensitization potency.
Key topics
- Introduction to the genomics and machine-learning based GARD® technology for quantitative skin sensitization potency assessment.
- Common challenges in deriving PoDs and establishing safe dose levels for skin sensitizers.
- Case studies on Fragrances, Complex Mixtures, and Biopesticides.
The webinar will last around 30 minutes, followed by a live Q&A. If you cannot attend the live event, make sure to register to get access to the recording.
Speakers
Andy Forreryd, PhD
Scientific Liaison Manager @ SenzaGen
- Co-developer of the GARD®skin assay (OECD TG 442E).
- Member of the ISO/TC 194/WG 8 on irritation and sensitization.
- Member of OECD expert group on respiratory sensitization.
Tim Lindberg, PhD
GARD® expert @ SenzaGen
- Co-developer of the GARD®skin assay (OECD TG 442E).
- Experienced scientist within immunology, genomics, and in vitro assay development.
